BAM
TNDM icon

Byrne Asset Management’s Tandem Diabetes Care TNDM Stock Holding History

Byrne Asset Management’s Portfolio TNDM Stock Details TNDM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-100
Closed -$4.5K – 635
2022
Q4 		$4.5K Buy
100
+40
+67% +$1.81K ﹤0.01% 445
2022
Q3 		$3K Sell
60
-65
-52% -$3.56K ﹤0.01% 457
2022
Q2 		$7K Sell
125
-100
-44% -$8.21K 0.01% 395
2022
Q1 		$26K Hold
225
– – 0.02% 275
2021
Q4 		$34K Buy
+225
New +$30.4K 0.02% 245

Other funds holding TNDM

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
EC
Eminence Capital New York $4.36B AUM 3.1% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Byrne Asset Management's TNDM Position: Q1 2023 in Review

Byrne Asset Management sold out of Tandem Diabetes Care (TNDM) in Q1 2023, closing a stake of 100 shares — an estimated $4.5K sold.

Byrne Asset Management first reported a position in TNDM in Q4 2021 and held it in 5 quarters. The position peaked at $34K in Q4 2021. 273 funds tracked by Wall St. Rank hold TNDM as of Q1 2023.

  • Byrne Asset Management reported no remaining Tandem Diabetes Care position as of Q1 2023 after selling out during the quarter.
  • Byrne Asset Management sold 100 Tandem Diabetes Care shares in Q1 2023, an estimated $4.5K.
  • Byrne Asset Management first reported a position in Tandem Diabetes Care in Q4 2021 and held it in 5 quarters.
  • Byrne Asset Management's Tandem Diabetes Care position peaked at $34K in Q4 2021.
  • 273 funds tracked by Wall St. Rank held Tandem Diabetes Care as of Q1 2023.

Based on Byrne Asset Management's 13F filing for Q1 2023, filed 17 Apr 2023.